Literature DB >> 30976990

Therapeutic strategies in the treatment of Menière's disease: the Italian experience.

Nicola Quaranta1, P Picciotti2, G Porro3, B Sterlicchio3, G Danesi4, P Petrone5, Giacinto Asprella Libonati6.   

Abstract

PURPOSE: Ménière's disease (MD) is an inner ear disorder of unknown etiology, whose pathological substrate is the endolymphatic hydrops. Different treatments have been proposed; however, evidence of their effectiveness is lacking. The aim of this study was to evaluate by a questionnaire which medical and surgical treatments are used in Italy for the treatment of MD and to compare them with those proposed in other countries.
METHODS: An electronic questionnaire of 40 questions was formulated and sent to Italian otolaryngologist (ENT) divided into two groups: Group 1 ("generalists" 60.8%) and Group 2 ("neurotologist- NO" 39.2%).
RESULTS: One hundred and twenty five ENT replied. Treatment of the acute phase, apart from symptomatics, was based on diuretics that are prescribed by 83.5% of respondents, steroids, prescribed by 66.7%, and vasodilators, prescribed by 22%. In the intercritical phase, 87.2% of respondents recommended low-salt diet, 78.4% of respondents prescribed betahistine, and 52.8% diuretics. Statistical analysis did not show correlation neither with the declared specialization nor with the number of patients treated. In case of failure of medical treatment, IT gentamicin was suggested by 48.8% of the respondents and IT steroids by 40.8%. Statistical analysis showed that generalists prefer IT steroids and NO IT gentamicin (p 0.019). In case of failure of both medical treatment and IT treatment, vestibular neurectomy was indicated by 58.4% of the respondents, 6.4% indicated endolymphatic sac surgery, and 2.4% surgical labyrinthectomy.
CONCLUSION: In Italy, the treatment of MD stand on a gradual approach that starts from the dietary-behavioral changes and a pharmacological therapy based on betahistine. In refractory cases, IT treatment initially with steroids and, therefore, with gentamicin allows the control in vertigo in the majority of cases. In case of failure of IT treatment, VNS is the surgery of choice.

Entities:  

Keywords:  Medical therapy; Menière; Questionnaire; Surgery

Mesh:

Substances:

Year:  2019        PMID: 30976990     DOI: 10.1007/s00405-019-05423-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  34 in total

1.  Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.

Authors:  Miroslav Novotný; Rom Kostrica
Journal:  Int Tinnitus J       Date:  2002

Review 2.  Ménière's disease.

Authors:  Lloyd B Minor; David A Schessel; John P Carey
Journal:  Curr Opin Neurol       Date:  2004-02       Impact factor: 5.710

3.  Long-term outcome of Ménière's disease: endolymphatic mastoid shunt versus natural history.

Authors:  A Quaranta; F Marini; V Sallustio
Journal:  Audiol Neurootol       Date:  1998 Jan-Feb       Impact factor: 1.854

Review 4.  International consensus (ICON) on treatment of Ménière's disease.

Authors:  J Nevoux; M Barbara; J Dornhoffer; W Gibson; T Kitahara; V Darrouzet
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2018-01-12       Impact factor: 2.080

5.  Hyperosmotic solutions and hearing Meniere's disease.

Authors:  C Angelborg; I Klockhoff; H C Larsen; J Stahle
Journal:  Am J Otol       Date:  1982-01

Review 6.  Meniere's disease.

Authors:  Tsutomu Nakashima; Ilmari Pyykkö; Megan A Arroll; Margaretha L Casselbrant; Carol A Foster; Nauman F Manzoor; Cliff A Megerian; Shinji Naganawa; Yi-Ho Young
Journal:  Nat Rev Dis Primers       Date:  2016-05-12       Impact factor: 52.329

7.  Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.

Authors:  Roberto Albera; Roberto Ciuffolotti; Maurizio Di Cicco; Giuseppe De Benedittis; Irene Grazioli; Gabriella Melzi; Eugenio Mira; Eugenio Pallestrini; Desiderio Passali; Agostino Serra; Claudio Vicini
Journal:  Acta Otolaryngol       Date:  2003-06       Impact factor: 1.494

8.  Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.

Authors:  Todd A Hillman; Douglas A Chen; Moises A Arriaga
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

9.  Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease.

Authors:  Augusto Pietro Casani; Elena Navari; Giorgio Guidetti; Michel Lacour
Journal:  Int J Otolaryngol       Date:  2018-10-25

10.  Prevalence, associated factors, and comorbid conditions for Ménière's disease.

Authors:  Jessica S Tyrrell; David J D Whinney; Obioha C Ukoumunne; Lora E Fleming; Nicholas J Osborne
Journal:  Ear Hear       Date:  2014 Jul-Aug       Impact factor: 3.570

View more
  1 in total

1.  The Effect of Endolymphatic Hydrops and Mannitol Dehydration Treatment on Guinea Pigs.

Authors:  Shu-Qi Wang; Chen-Long Li; Jing-Qi Xu; Li-Li Chen; You-Zhou Xie; Pei-Dong Dai; Liu-Jie Ren; Wen-Juan Yao; Tian-Yu Zhang
Journal:  Front Cell Neurosci       Date:  2022-04-11       Impact factor: 6.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.